Boston Scientific Corp. Stock Slides 5.9%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Boston Scientific Corp. slipped 5.9% to $44.98 on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.6% to 7,673.52 and Dow Jones Industrial Average falling 1.2% to 52,786.07.

Boston Scientific Corp. closed 58.9% below its 52-week high of $109.50, which the company achieved on September 9th.

The stock demonstrated a mixed performance when compared to some of its peers, as Abbott Laboratories fell 2.6% to $105.52, Medtronic PLC fell 1.9% to $92.39, and Stryker Corp. fell 8.81% to $276.43.

Trading volume totaled 29.0 million, compared to the 50-day average of 20.0 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 08, 2026 16:34 ET (20:34 GMT)